CFAR Scientific Symposium

This was designed for all HIV/AIDS investigators. The symposium presented a comprehensive series of lectures. They reviewed the new basic, clinical, and behavioral studies providing insights into the biology of HIV prevention and treatment.

Keynote Address

• Facing the Social and Behavioral Challenges of the AIDS Epidemic
  Margaret A. Chesney, PhD

Session 1

Moderator: Charles C.J. Carpenter, MD

• New Insights into the Structure and Function of HIV Envelope Glycoproteins from CD4-Independent Virus
  James A. Hoxie, MD
• HIV Coreceptors as Determinants of Disease Pathogenesis
  Mark A. Goldsmith, MD, PhD
• Discussion

Session 2

Moderator: William T. Shearer, MD, PhD

• Cyclophilin A Function in HIV-1 Replication and in CD4+ T Cells
  Jeremy Luban, MD
• Entry Processes of HIV in Search of New Antiviral Targets
  Eric Hunter, PhD
• Discussion

Breakout Sessions

• Prospects for a protective HIV vaccine
  Jay Levy, MD and Fred Valentine, MD
• Vertical transmission: where are we, where should we go?
  Karen Beckerman, MD and King Holmes, MD, PhD
• Defining the immune response to HIV
  Joseph M. (Mike) McCune, MD, PhD and Kent Weinhold, PhD
• The pathogenic impact of HIV resistance
  Robert Grant, MD, MPH, MS and Ronald I. Swanstrom, PhD
• New molecular targets for HIV drug development
  Charles S. Craik, PhD and Flossie Wong-Staal, PhD

Session 3

Moderator: James O. Kahn, MD

• Presentation
  Grace C. John, MD, MPH
• Microbicides and the Prevention of HIV Transmission
  Sharon L. Hillier, PhD

Session 4

Moderator: Michael M. Lederman, MD

• Applications of Developed Technologies in the Developing World
  Susan Allen, MD, MPH, DTM&H
• The Consequences of Combination Anti-HIV Therapies in the Developed World
  Steven G. Deeks, MD